Cortexyme, Inc.
IPO News: Filed S-1: Cortexyme Files $86.3mm IPO
Cortexyme, Inc.

Cortexyme

NASDAQ:  CRTX

Size (mm):  $86.3

Bookrunners:  BAML | CS

Major Holders: Pfizer | Pierre R. and Christine E. Lamond | Takeda Venture | Smallcap World Fund | Blue Devil Trust | Stephen S. Dominy | Casey C. Lynch

Description: Cortexyme is a clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to treat what they believe to be a key underlying cause of Alzheimer’s and other degenerative diseases.

Note: Emerging Growth Company

Reference Link: S-1